ACCC blocks Alliance Aviation-Qantas tie up

Nick Sundich Nick Sundich, April 20, 2023

Alliance Aviation (ASX:AQZ), a charter airline, looked set to be acquired by Qantas, but the ACCC has put the plans on ice.

The competition regulator has indicated that will oppose the proposed deal due to concerns that the deal will lessen competition.

 

No time to do stock research, but you still want to invest?

 

Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

Alliance Aviation

Qantas first acquired a 19.9% stake in Alliance Aviation in 2019 and made a bid for the balance of shares in May 2022.

Although the ACCC had previously declined to take action against the initial acquisition, it hit the brakes here.

It concluded that the deal would lessen industry competition in the industry, noting that both were amongst the largest suppliers of charter services in WA and Queensland.

 

What now?

Both companies expressed disappointment in the decision. Alliance Aviation told shareholders it would consider the ACCC’s decision and its options before deciding on its next step.

Qantas went further and told shareholders it formally requested a meeting with the ACCC and noted that there was significant industry competition, with customers having strong bargaining power in their negotiations with operators.

Qantas and Alliance Aviation both want the deal to go ahead, but it won’t without ACCC approval which clearly is not coming any time soon.

 

 

Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

There’s no credit card needed – the trial expires automatically.

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Telix Pharmaceuticals on the Nasdaq

Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!

What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful…

anti woke ETFs

Anti Woke ETFs: Do they practice what they preach and have they outperformed since Trump’s return to power?

Have you ever heard of so-called ‘Anti Woke ETFs’? If you’re sick of companies that are big on ESG, this…

Trump Tariffs

Trump’s Tariffs Are Back in the News—What’s the Impact on Global Supply Chains?

In recent months, the conversation around trade tariffs has re-emerged, with former President Donald Trump’s trade policies making headlines once…